| P2093 | author name string | Joseph K Lim | |
| | AnnMarie Liapakis | |
| P2860 | cites work | Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis C | Q22305322 |
| | Telaprevir for previously untreated chronic hepatitis C virus infection | Q29619800 |
| | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 |
| | Boceprevir for untreated chronic HCV genotype 1 infection | Q29620617 |
| | Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome | Q29620780 |
| | Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA. | Q33834953 |
| | Preliminary study of two antiviral agents for hepatitis C genotype 1. | Q34030288 |
| | Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. | Q34320498 |
| | Current prospects for interferon-free treatment of hepatitis C in 2012. | Q38058555 |
| | Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States☆☆☆ | Q39844102 |
| | Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders | Q43041150 |
| | Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus | Q45364058 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic hepatitis C | Q55779873 |
| P304 | page(s) | 822-826 | |
| P577 | publication date | 2013-08-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Impact of rapid point-of-care screening tests for the identification of chronic hepatitis C infection | |
| P478 | volume | 58 | |